📣 VC round data is live. Check it out!
- Public Comps
- Abbott India
Abbott India Valuation Multiples
Discover revenue and EBITDA valuation multiples for Abbott India and similar public comparables like PTC Therapeutics, Scholar Rock, Celcuity, Terns Pharma and more.
Abbott India Overview
About Abbott India
Abbott India Ltd is a drug manufacturing company that offers products in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. Its patient focus centers overwhelmingly on women's health and gastrointestine, gastroenterology, and hepatic care. Geographically, the majority of the company's revenue is generated in India.
Founded
1944
HQ

Employees
3.7K
Website
Financials (LTM)
EV
$6B
Valuation Multiples
Start free trialAbbott India Financials
Abbott India reported last 12-month revenue of $732M and EBITDA of $201M.
In the same LTM period, Abbott India generated $342M in gross profit, $201M in EBITDA, and $165M in net income.
Revenue (LTM)
Abbott India P&L
In the most recent fiscal year, Abbott India reported revenue of $670M and EBITDA of $206M.
Abbott India is profitable as of last fiscal year, with gross margin of 45%, EBITDA margin of 31%, and net margin of 22%.
Financial data powered by Morningstar, Inc.
Abbott India Stock Performance
Abbott India has current market cap of $6B, and enterprise value of $6B.
Market Cap Evolution
Abbott India's stock price is $285.06.
Abbott India share price increased by 6.4% in the last 30 days, and decreased by 13.5% in the last year.
Abbott India has an EPS (earnings per share) of $6.96.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $6B | $6B | 1.1% | 6.4% | 0.5% | -13.5% | $6.96 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAbbott India Valuation Multiples
Abbott India trades at 8.0x EV/Revenue multiple, and 29.1x EV/EBITDA.
EV / Revenue (LTM)
Abbott India Financial Valuation Multiples
As of May 14, 2026, Abbott India has market cap of $6B and EV of $6B.
Abbott India has a P/E ratio of 36.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Abbott India Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Abbott India Margins & Growth Rates
Abbott India grew revenue by 8% but EBITDA decreased by 4% in the last fiscal year.
In the most recent fiscal year, Abbott India reported gross margin of 45%, EBITDA margin of 31%, and net margin of 22%.
Abbott India Margins
Abbott India Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Abbott India Operational KPIs
Abbott India's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
Abbott India's Rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Abbott India's Rule of X is 49% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Abbott India Competitors
Abbott India competitors include PTC Therapeutics, Scholar Rock, Celcuity, Terns Pharma, Centessa Pharmaceuticals, Corcept Therapeutics, Belite Bio, Immunovant, Hebei Changshan and Salubris Pharmaceuticals.
Most Abbott India public comparables operate across Biopharmaceuticals, Medical Devices, BioTech, DeepTech, FemTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 2.7x | 3.0x | 5.1x | 6.9x | |||
| — | 2434.7x | (15.5x) | (14.2x) | |||
| — | 280.3x | (36.9x) | (30.4x) | |||
| — | — | — | — | |||
| 397.7x | 628.5x | (32.5x) | (26.7x) | |||
| 7.6x | 6.9x | 44.5x | 46.3x | |||
| — | 685.0x | (73.4x) | (61.5x) | |||
| — | — | (12.3x) | (10.7x) | |||
This data is available for Pro users. Sign up to see all Abbott India competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Abbott India
| When was Abbott India founded? | Abbott India was founded in 1944. |
| Where is Abbott India headquartered? | Abbott India is headquartered in India. |
| How many employees does Abbott India have? | As of today, Abbott India has over 3K employees. |
| Is Abbott India publicly listed? | Yes, Abbott India is a public company listed on National Stock Exchange of India. |
| What is the stock symbol of Abbott India? | Abbott India trades under ABBOTINDIA ticker. |
| When did Abbott India go public? | Abbott India went public in 2010. |
| Who are competitors of Abbott India? | Abbott India main competitors include PTC Therapeutics, Scholar Rock, Celcuity, Terns Pharma, Centessa Pharmaceuticals, Corcept Therapeutics, Belite Bio, Immunovant, Hebei Changshan, Salubris Pharmaceuticals. |
| What is the current market cap of Abbott India? | Abbott India's current market cap is $6B. |
| What is the current revenue of Abbott India? | Abbott India's last 12 months revenue is $732M. |
| What is the current revenue growth of Abbott India? | Abbott India revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Abbott India? | Current revenue multiple of Abbott India is 8.0x. |
| Is Abbott India profitable? | Yes, Abbott India is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Abbott India? | Abbott India's last 12 months EBITDA is $201M. |
| What is Abbott India's EBITDA margin? | Abbott India's last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Abbott India? | Current EBITDA multiple of Abbott India is 29.1x. |
| What is the current FCF of Abbott India? | Abbott India's last 12 months FCF is $155M. |
| What is Abbott India's FCF margin? | Abbott India's last 12 months FCF margin is 21%. |
| What is the current EV/FCF multiple of Abbott India? | Current FCF multiple of Abbott India is 37.7x. |
| How many companies Abbott India has acquired to date? | Abbott India hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Abbott India has invested to date? | Abbott India hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Abbott India
Lists including Abbott India
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.